Published Studies

Autoimmune Brain Panel™ Studies

Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism
Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism

PUBLISHED: TRANSLATIONAL PSYCHIATRY

Study results suggest that the autoimmune targets in the Panel can predict IVIG treatment response in a subset of autism patients.

Case Report: PANDAS and Persistent Lyme Disease With Neuropsychiatric Symptoms
Case Report: PANDAS and Persistent Lyme Disease With Neuropsychiatric Symptoms: Treatment, Resolution, and Recovery

PUBLISHED: FRONTIERS IN PSYCHIATRY

A previously asymptomatic, healthy 7-year-old girl experienced an abrupt onset of several physical, neurological, and psychiatric symptoms increasing in intensity over a 3-week period.

Autoantibody biomarkers for basal ganglia encephalitis
Autoantibody biomarkers for basal ganglia encephalitis in Sydenham chorea and pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections

PUBLISHED: FRONTIERS IN PSYCHIATRY

Dr. Madeleine Cunningham, co-author, reviews the utilization of antineuronal antibodies (measured with the Panel) as biomarkers for infection-triggered, autoimmune, basal ganglia encephalitis and the significance of the CaMKinase II.

Anti-lysoganglioside and other anti-neuronal autoantibodies in post-treatment Lyme Disease
Anti-lysoganglioside and other anti-neuronal autoantibodies in post-treatment Lyme Disease and Erythema Migrans after repeat infection

PUBLISHED: BRAIN, BEHAVIOR & IMMUNITY

The Panel results indicate Lyme disease may trigger an autoimmune dysfunction, as elevated neuronal autoantibodies have been associated with persistent symptoms.

Evaluation of the Cunningham Panel™ in PANDAS and PANS
Evaluation of the Cunningham Panel™ in PANDAS and PANS: Changes in antineuronal antibody titers parallel changes in patient symptoms

PUBLISHED: JOURNAL OF NEUROIMMUNOLOGY

Dr. Craig Shimasaki, CEO and President, Moleculera Labs, reviews findings from the study, which describes the sensitivity, specificity and accuracy of the Cunningham Panel™ for patients with PANS and PANDAS.

An atypical presentation of Pediatric Acute Neuropsychiatric Syndrome responding to plasmapheresis treatment

PUBLISHED: CASE REPORTS IN PSYCHIATRY

An atypical presentation of Pediatric Acute Neuropsychiatric Syndrome responding to plasmapheresis treatment. Case review: Dr. Shimasaki

Learn how the Autoimmune Brain Panel™ can aid in the diagnosis of neuropsychiatric disorders.